RxDoctor Payments Data

Gregory Parker, MD

Family Medicine · Columbus, GANPI 1851392575

Payments from drug & device makers

$12,250in general payments, 2019–2025

Across 814 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$956
  • AstraZeneca$922
  • Astellas Pharma US Inc$724
  • Amgen$624
  • plus $6K from 49 others

What the payments were for

  • Food & beverage$12,222100%
  • Education$280%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,250 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$824,173
Medicare patients
4,076
Services billed
59,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$118,345
OzempicSemaglutide88$94,964
JanuviaSitagliptin Phosphate49$66,254
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$54,967
XareltoRivaroxaban60$53,058
MounjaroTirzepatide39$42,763
FarxigaDapagliflozin Propanediol44$41,151
RybelsusSemaglutide18$25,675
JardianceEmpagliflozin24$25,035
ShingrixVaricella-Zoster Ge/As01b/Pf79$17,336
AbrysvoRsv Vacc, Pref A And Pref B/Pf43$13,801
InvokanaCanagliflozin13$10,779
LinzessLinaclotide16$10,094
Colesevelam Hcl30$10,031
MyrbetriqMirabegron13$7,016

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$568$132,146156 claims
Novo NordiskOzempic, Rybelsus$1,382$120,639106 claims
GSKTrelegy Ellipta, Shingrix$208$72,303139 claims
MerckJanuvia$164$66,25449 claims
Johnson & JohnsonXarelto, Invokana$286$63,83673 claims
AstraZenecaFarxiga, Symbicort$922$44,56957 claims
Lilly USA, LLCMounjaro$956$42,76339 claims
Boehringer IngelheimJardiance, Trijardy Xr$271$31,64635 claims
AbbVieLinzess$1,433$10,09416 claims
Astellas Pharma US IncMyrbetriq$724$7,01613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →